International Stem Cell Corp (OTCBB:ISCO) is a company to watch this year, with several promising developments in store, according to a conference call with investors this morning.The company, whose parthenogenetic stem cell technology can be used to derive pluripotent stem...
opinion by pjbosc | 26 wks ago 120 views | 0 recommendations | 0 comments
Sign up: USDA June 29th deadline to halt GE, drug and industrial chemicals in food crops
Many social welfare, health and environmental organizations are asking Americans to sign up before June 29 to halt the...
created by NonGMOTalk | 2 years ago | updated 2 years ago 154 views | 0 recommendations | 0 comments
A decade after safety concerns were first raised by experts, the Occupational Safety and Health Administration (OSHA) conducted public hearings on Diacetyl – a chemical widely used to flavor microwave popcorn. The public comment period ended on April 21st.
Recent...
created by NonGMOTalk | 2 years ago | updated 2 years ago 1378 views | 0 recommendations | 0 comments
Listen to this week's edition of the "Weekly Radio Spin," the Center for Media and Democracy's audio report on the stories behind the news. This week, corporate healthcare gets the vapors, GM's new spinmeister and...
As anyone who has ever heard about what companies like Monsanto do behind closed doors would already know, biotechnology remains a gray, and apparently somewhat shady, area. There are growing concerns over the...
created by Geneva B | 2 years ago | updated 2 years ago 330 views | 23 recommendations | 9 comments
It is just what we have been saying all along. The thugs on wall street have been crushing the stocks of certain companies that do cancer research. Here is the undisputed proof of what has been going on with...
opinion by RoryKearney | 3 years ago | updated 3 years ago 1156 views | 6 recommendations | 4 comments
BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced financial and operational results for the third quarter ended September 30, 2008. BioMS Medical, in partnership with Eli Lilly and Company (Lilly), is developing...
created by Culley | 3 years ago 104 views | 0 recommendations | 1 comment
While his fellow scientists are trying to understand the origins of Bing Bang at CERN, Vladimir Rudenov is trying to get to the root of a scientific problem much closer to home…smelly feet. The concept is...
created by Yuliya Talmazan | 3 years ago | updated 3 years ago 1971 views | 0 recommendations | 3 comments
"If you've filled your tank with gas, or warmed your home with natural gas, there's a chance you sent money to Abu-Dhabi.
So it might come as a surprise to learn that Abu Dhabi is this week hosting the world's first Future Energy Summit, a three-day gathering of more than...
I'd rather give my spare cash to the Sally Ann Mission this Christmas. Guess the Paris Hiltons and other LaLa Celebrities will be giving themselves this holiday season? Guess adopting everything from...
created by Barry ORegan | 4 years ago | updated 4 years ago 2336 views | 10 recommendations | 2 comments
"What would happen if technology could deliver a renewable way of creating gasoline in relative minutes as opposed to the millions and millions of years it takes to create the base of gasoline we pump out of the...
created by Edmund Jenks | 4 years ago | updated 4 years ago 1118 views | 0 recommendations | 0 comments
This is a step beyond the purported 10-wing chickens being grown for KFC... Pharming raises all sorts of moral questions, primarily regarding the value of the life of an animal bred versus that of an animal born in the wild: animals experimented on are animals killed, which...
"#1 Future of Internet Debate Ignored by Media
Sources:
Buzzflash.com, July 18, 2005
Title: “Web of Deceit: How Internet Freedom Got the Federal Ax, and Why Corporate News Censored the Story”
Author: Elliot D....
created by happytribe | 4 years ago | updated 4 years ago 4919 views | 1 recommendation | 0 comments
"British scientists are on the verge of producing a revolutionary flu vaccine that works against all major types of the disease.
Described as the 'holy grail' of flu vaccines, it would protect against all strains of influenza A - the virus behind both bird flu and the...
BOSTON (AP) - The
average drug manufactured by the biotechnology industry costs $1.2
billion and takes a little more than eight years to develop, according
to a study released Thursday by the Tufts Center for the Study of Drug
Development.
created by Benton | 5 years ago | updated 5 years ago 192 views | 0 recommendations | 0 comments